×

Access Whitepaper

First Name
Last Name
Company
Thank you!
Error - something went wrong!
   

Compensating Participants in Clinical Research: Current Thinking

December 5, 2017

Sponsors, researchers and Institutional Review Boards (IRBs) are often wary about payments in research participation, citing concerns about coercion and undue influence, whether real or perceived, and have avoided payments that are “too high.” New research on how people make decisions about research participation, and new approaches to this question, bring a new perspective; are payments to participants actually too low? This paper explores this question, and whether we should, in fact, worry much less about restricting compensation for research participants.Enter content here

Previous Flipbook
Site-specific, Patient-centered and Whip-smart: Enrollment Assistants Adapt to a Shifting Landscape
Site-specific, Patient-centered and Whip-smart: Enrollment Assistants Adapt to a Shifting Landscape

Next Flipbook
Virtual Clinical Trials Best Practices
Virtual Clinical Trials Best Practices

Request a Genetics in Clinical Trials training session

What You'll Learn